SLU-PP-332 is a novel synthetic pan-agonist of the estrogen-related receptors (ERR, ERR, ERR), originally developed at Saint Louis University and characterised in recent pre-clinical literature as an exercise mimetic. It is widely studied in research models exploring mitochondrial biogenesis, fatty-acid oxidation, and metabolic endurance
Holst 2007)
This approach ensures your cells are "primed" for the day ahead
10.1111/j.1651-2227.1989.tb11205.x 53
It works best as a complement to the diet and habits above, not a replacement for them, and it is worth checking with your clinician or pharmacist first if you take medication or manage a health condition
Researchers can explore additional educational resources through the Frontier Peptide Research Library, which features articles covering peptide biology, molecular signaling, laboratory methodologies, analytical chemistry, peptide handling, and current peptide research topics